Scarica l'app Stockscreener
13.38
2.69%
-0.37
Dopo l'orario di chiusura:
13.21
-0.17
-1.27%
Precedente Chiudi:
$13.75
Aprire:
$13.34
Volume 24 ore:
125.03K
Relative Volume:
1.48
Capitalizzazione di mercato:
$406.32M
Reddito:
-
Utile/perdita netta:
$-1.77M
Rapporto P/E:
-89.98
EPS:
-0.1487
Flusso di cassa netto:
$-1.46M
1 W Prestazione:
+32.87%
1M Prestazione:
+39.38%
6M Prestazione:
+282.29%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$13.03
$14.29
Intervallo di 1 settimana:
$9.70
$14.39
Portata 52W:
$2.5701
$26.50
Turn Therapeutics Inc Stock (TTRX) Company Profile
Nome
Turn Therapeutics Inc
Settore
Industria
Telefono
(818) 564-4011
Indirizzo
250 NORTH WESTLAKE BLVD., WESTLAKE VILLAGE
Compare TTRX vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TTRX
Turn Therapeutics Inc
|
13.38 | 417.56M | 0 | -1.77M | -1.46M | -0.1487 |
VRTX
Vertex Pharmaceuticals Inc
|
514.56 | 132.08B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
793.26 | 83.15B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
984.04 | 62.71B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
136.62 | 54.14B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
203.35 | 44.51B | 742.00K | -1.37B | -1.07B | -7.0731 |
Turn Therapeutics Inc Stock (TTRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-29 | Iniziato | D. Boral Capital | Buy |
Turn Therapeutics Inc Borsa (TTRX) Ultime notizie
Turn Therapeutics to Present at Stifel 2026 Virtual Immunology and Inflammation Forum - biospace.com
Turn Therapeutics to present at Stifel forum, previewing atopic dermatitis program - TradingView
Turn Therapeutics to Present Atopic Dermatitis Strategy - TipRanks
Former CDC Director Dr. Robert R. Redfield Named Chief Scientific Officer at Turn Therapeutics - The Dermatology Digest
Turn Therapeutics Names Former CDC Director Robert Redfield Chief Scientific Officer - citybiz
Turn Therapeutics Appoints Former CDC Director Robert R. Redfield, M.D., as Chief Scientific Officer - biospace.com
Turn Therapeutics Names Robert Redfield Chief Scientific Officer - TipRanks
Former CDC Director Robert Redfield Joins Turn Therapeutics as Chief Scientific Officer - Dermatology Times
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
TTRX - Finviz
Turn Therapeutics (NASDAQ:TTRX) Rating Lowered to Sell at Wall Street Zen - MarketBeat
Ieq Capital LLC Makes New Investment in Turn Therapeutics Inc. $TTRX - MarketBeat
Turn (TTRX) Levels: Records a 2.33% Increase to $9.68 in the Current Update; Levels: $9.20 and $10.16 Define the Nearby Reference Levels in the Latest SessionContinuation Pattern Picks - vinanet.vn
Turn (TTRX) Session: Records a 0.84% Decrease to $9.46 on the Day; Range Check: Traders Can Monitor the $8.99-$9.93 Range in the Available RecordFibonacci Entry Signals - vinanet.vn
Turn (TTRX) Results Breakdown: Available Metrics Are Broadly in Line for the Current Session; After Earnings: The Stock Ends Down 2.85% at the CloseGuidance Accuracy Score - vinanet.vn
Turn (TTRX) Close: Ends Lower by 0.20% at $9.80 on the Day; Current Setup: Traders Can Monitor the $9.31-$10.29 Range in Latest TradingWedge Breakout - vinanet.vn
GX-03 Selectively Reduces Key Drivers of Skin Inflammation, Itch - The Dermatology Digest
GX-03 Cuts Itch-Related Cytokine IL-31 by Nearly 68% in AD Model - Dermatology Times
Turn Therapeutics publishes study on GX-03 skin therapy - Investing.com
Turn Therapeutics publishes study on GX-03 skin therapy By Investing.com - Investing.com Canada
Turn Therapeutics Announces New Peer-Reviewed Research Showing GX-03 Selectively Reduces Key Drivers of Skin Inflammation and Itch - Business Wire
Turn Therapeutics Issues 579,664 Shares in Cashless Warrant Exercise - Minichart
Form 8K Turn Therapeutics Inc For: 18 August By Investing.com - Investing.com South Africa
Turn Therapeutics Reports Unregistered Cashless Warrant Share Issuance - TipRanks
Turn Therapeutics Completes Cashless Exercise of GEM Warrant, Issues 579,664 Shares - Kalkine Media
Turn Therapeutics Raises $1.35 Million in Private Placement - Minichart
Turn Therapeutics Secures $1.35 Million Through Private Stock Placement - Kalkine Media
Turn Therapeutics Raises $1.35M Through Private Placement - TipRanks
Turn Therapeutics (TTRX) Rallies 3.55% to $9.91, Approaching Key $10.41 ResistanceBeta Neutral Pair - vinanet.vn
Ladenburg Thalmann Initiates Turn Therapeutics(TTRX.US) With Buy Rating, Announces Target Price $16 - Moomoo
Turn Therapeutics (NASDAQ:TTRX) Stock Price Down 6.5%Time to Sell? - MarketBeat
Turn Therapeutics Inc. announced that it expects to receive $1.35 million in funding - marketscreener.com
Turn Therapeutics (TTRX) Falls 5.6% to $9.95 as Support at $9.45 Comes into FocusRetracement Entry - vinanet.vn
Turn Therapeutics Announces Q2 2026 Financial Results with Increased Net Loss and Long-Term Debt - Kalkine Media
Form 8K Turn Therapeutics Inc For: 12 August By Investing.com - Investing.com Nigeria
Turn Therapeutics (NASDAQ: TTRX) posts larger loss, adds debt and warns on going concern - Stock Titan
Turn Therapeutics Q2 net loss per share widens on higher R&D costs - TradingView
Turn Therapeutics Provides Corporate Updates and Reports Second Quarter 2026 Financial Results - Yahoo Finance
Turn Therapeutics Rings the Nasdaq Stock Market Closing Bell - Nasdaq
Turn Therapeutics Rings the Closing Bell - Nasdaq
Turn Therapeutics Ord Shs (TTRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Price to sales forward of Turn Therapeutics Inc. – NASDAQ:TTRX - TradingView
Turn Therapeutics (TTRX) Advances 3.82% to $8.56 as Biotech Buying Interest IntensifiesValue ETF - vinanet.vn
Turn Therapeutics Inc. Revenue Breakdown – NASDAQ:TTRX - TradingView
Turn Therapeutics Updates GX-03 Investor Presentation and Pipeline - TipRanks
Turn updates investor presentation, cites Q4 2026 AD Phase 2 topline and $11.2M cash - TradingView
GX-03 trial data and cash runway at Turn Therapeutics (NASDAQ: TTRX) - Stock Titan
Turn Therapeutics to Ring the Nasdaq Closing Bell on Monday, August 10, 2026 - Business Wire
Turn Therapeutics Ord Shs (TTRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TTRX|Turn Therapeutics Ord Shs|Price:9.575|Chg%:+0.735 - TradingKey
Turn Therapeutics (TTRX) Plunges Nearly 10% as Stock Approaches Key Support ZoneFactor Momentum - vinanet.vn
Turn Therapeutics Inc Azioni (TTRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):